Galera Therapeutics Inc
General ticker "GRTX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.8M
Galera Therapeutics Inc does not follow the US Stock Market performance with the rate: -45.8%.
Estimated limits based on current volatility of 6.3%: low 0.03$, high 0.03$
Factors to consider:
- Current price 50.6% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.06$, 0.40$]
- 2024-12-30 to 2025-12-30 estimated range: [0.05$, 0.27$]
Financial Metrics affecting the GRTX estimates:
- Negative: Non-GAAP EPS, $ of -1.41 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -88.10 <= 2.35
- Negative: negative Net income
- Negative: Industry operating profit margin (median), % of -98.30 <= 2.14
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
Short-term GRTX quotes
Long-term GRTX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $73.37MM | $51.23MM | $46.95MM |
| Operating Income | $-73.37MM | $-51.23MM | $-46.95MM |
| Non-Operating Income | $-7.17MM | $-11.07MM | $-12.13MM |
| Interest Expense | $7.19MM | $11.57MM | $0.00MM |
| R&D Expense | $52.42MM | $31.01MM | $24.11MM |
| Income(Loss) | $-80.53MM | $-62.29MM | $-59.08MM |
| Taxes | $0.00MM | $0.07MM | $0.00MM |
| Profit(Loss) | $-80.53MM | $-62.36MM | $-59.08MM |
| Stockholders Equity | $-58.00MM | $-109.18MM | $-131.19MM |
| Assets | $83.31MM | $44.04MM | $26.14MM |
| Operating Cash Flow | $-67.96MM | $-43.43MM | $-44.85MM |
| Capital expenditure | $0.28MM | $0.03MM | $0.06MM |
| Investing Cash Flow | $5.24MM | $23.99MM | $27.29MM |
| Financing Cash Flow | $66.71MM | $3.89MM | $31.50MM |
| Earnings Per Share* | $-3.40 | $-2.30 | $-1.33 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.